Luciana Urruty is a 26-year-old former textile designer and assistant professor in the School of Design of Uruguay. Yes, she lives in Uruguay and speaks Spanish and a little English. After 5 years of work, Luciana decided to quit the fashion industry in order to pursue something that gave her more purpose in life.
Diagnosed with type 1 diabetes at age 15, Luciana was inspired when she saw our contest video earlier this year. She…
Read more »
By
WilD on
April 30, 2011
Our controversial columnist Wil Dubois is back with another spicy edition of our new diabetes advice column, Ask D’Mine.
{Need help navigating life with diabetes? Email us at AskDMine@diabetesmine.com}
You know the answers you get here will be brutally honest and interesting, to say the least.
Robyn from Colorado, type 1, writes: I have traveled a lot over the years with my insulin in tow. Upon completion of each trip I always come to the…
Read more »
By
WilD on
March 26, 2011
Welcome back to our spankin’ new diabetes advice column, Ask D’Mine. We just kicked off this series last week, and we’re already getting lots of queries — so thank you, Curious PWDs! As a reminder:
This is a place to send all your quirky or potentially embarrassing questions, behind-the-scenes curiosities, lifestyle queries, or even ethical dilemmas related to life with the Big D.
“Need help navigating life with diabetes? Email us at AskDMine@diabetesmine.com“
And now, to…
Read more »
By
AmyT on
January 24, 2011
I can’t help it. This reminds me of the movie City Slickers, in which one of the characters has messed up his life, and his friends tell him he’s getting a “do-over.” The young company Dance Pharmaceuticals, based in downtown San Francisco, is basically on a mission to salvage the good parts of Pfizer’s failed inhaled insulin Exubera (not the awkward delivery device!) and launch a second coming of the base product that is “simpler,…
Read more »
By
AmyT on
January 3, 2011
Happy New Year, everyone! I’ve been mostly off-line this past week, attempting to enjoy the “break” while cleaning and sorting out our fresh-from-construction home. But even in that daze, I couldn’t help noticing all the fuss about MannKind’s Afrezza, which was supposed to be ruled upon by the FDA on Dec. 29.
The FDA has requested an additional four weeks to make a decision on this new inhalable insulin, after having postponed the decision by…
Read more »
